Regencell Bioscience Holdings Ltd (RGC) Institutional Ownership

Ownership Summary

Regencell Bioscience Holdings Ltd (NASDAQ:RGC) showed up in the 13F filings of 17 institutional investors as of December 2025.

• Their combined ownership stood at 0.1% of outstanding shares in December 2025, down from 0.1% in September 2025.
• Their total shares held in RGC increased 2.9% from the prior quarter, while the number of investors in Regencell Bioscience Holdings stayed flat year over year.
• During the quarter, 11 of these 17 funds increased positions in RGC, 4 reduced exposure, and 2 held steady.
• In total, institutional investors held 548.42K shares in Regencell Bioscience Holdings as of December 2025, up by 15.47K shares quarter on quarter, and up 539.77K shares year over year.
• As of December 31, 2025, GEODE CAPITAL MANAGEMENT, LLC held the largest stake in Regencell Bioscience Holdings with 413.08K shares, accounting for 0.08% of total shares outstanding.
• Top purchasers of RGC stock for the quarter ending December 2025 included UBS Group AG (17.82K), XTX Topco Ltd (15.08K), Hudson Bay Capital Management LP (13.11K), Vident Advisory, LLC (11.87K), Seven Fleet Capital Management LP (4.4K).
• The biggest sellers of Regencell Bioscience Holdings for the quarter ending December 2025 included Squarepoint Ops LLC (25.24K), Morgan Stanley (16.42K), GEODE CAPITAL MANAGEMENT, LLC (6.89K), Bank Of America Corp /De/ (1).
• Business Quant data shows the 10 biggest positions in Regencell Bioscience Holdings as of December 2025 are held by GEODE CAPITAL MANAGEMENT, LLC (413.08K), Vident Advisory, LLC (29.93K), Squarepoint Ops LLC (26.01K), Morgan Stanley (21.42K), UBS Group AG (18.2K), XTX Topco Ltd (15.08K), Hudson Bay Capital Management LP (13.11K), BlackRock, Inc. (4.86K), Seven Fleet Capital Management LP (4.4K), EverSource Wealth Advisors, LLC (550).